Myomo, Inc.

Name: Myomo, Inc. standardized financial statements, quarterly
Creator: Listed

MYONYSECIK 1369290HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.7m, Q2 FY2026

Operating income−$2.3m, Q2 FY2026

Net income−$4.0m, Q2 FY2026

Myomo, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	5.1	4.8	3.8	7.5	9.2	12.1	9.8	9.7	10.1	11.4	10.1	11.7
Cost of revenue	$m	1.6	1.7	1.5	2.2	2.3	3.5	3.2	3.6	3.6	3.6	3.2	3.3
Gross profit	$m	3.5	3.1	2.3	5.3	6.9	8.6	6.6	6.1	6.4	7.8	6.9	8.4
Research and development	$m	0.7	0.9	1.0	1.0	1.2	1.6	1.8	2.0	1.5	1.6	1.6	1.7
Selling, general and administrative	$m	4.8	4.7	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$m	(2.0)	(2.4)	(3.9)	(1.1)	(1.0)	(0.2)	(3.5)	(4.6)	(3.5)	(2.8)	(3.2)	(2.3)
Income tax	$m	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0
Net income	$m	(2.0)	(2.5)	(3.8)	(1.1)	(1.0)	(0.3)	(3.5)	(4.6)	(3.7)	(3.8)	(3.0)	(4.0)
Diluted EPS	$ per share	(0.06)	not reported	(0.10)	(0.03)	(0.03)	not reported	(0.08)	(0.11)	(0.09)	not reported	(0.07)	(0.09)
Basic EPS	$ per share	(0.06)	not reported	(0.10)	(0.03)	(0.03)	not reported	(0.08)	(0.11)	(0.09)	not reported	(0.07)	(0.09)

Balance sheet

Cash and equivalents$11.2m, Q2 FY2026

Long-term debt$11.5m, Q2 FY2026

Shareholders' equity$5.8m, Q2 FY2026

Myomo, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	6.9	6.9	5.4	5.8	6.6	24.4	19.8	14.2	12.6	14.1	11.4	11.2
Current assets	$m	16.0	13.7	15.7	15.1	14.7	32.8	31.1	28.0	22.9	27.6	25.7	24.5
Total assets	$m	17.1	14.6	16.5	16.2	16.3	42.2	40.9	38.7	34.1	38.6	36.8	35.3
Current liabilities	$m	5.8	5.5	5.6	6.5	7.0	10.2	11.7	11.8	9.2	8.3	9.4	10.6
Total liabilities	$m	6.0	5.6	5.6	6.5	7.0	17.5	19.2	21.1	19.5	27.2	27.8	29.5
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	11.2	not reported	1.3	2.4	11.2	10.9	11.5
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	3.0	not reported	0.2	0.6	0.0	2.7	0.4
Shareholders' equity	$m	11.0	9.0	10.9	9.7	9.3	24.7	21.7	17.6	14.6	11.4	9.0	5.8

Cash flow

Operating cash flow−$1.9m, Q2 FY2026

Capital expenditure$32.4k, Q2 FY2026

Myomo, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,715)	(2,356)	(3,246)	(1,916)	(1,494)	3,366	(2,677)	(8,865)	(1,829)	(1,140)	(2,197)	(1,944)
Capital expenditure	$k	54.1	31.7	59.8	119	321	860	671	221	2,089	(1,239)	328	32.4

Diluted shares (weighted)42.70m, Q2 FY2026

Myomo, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	7.1	24.2	28.0	35.3	36.8	37.4	38.0	41.5	41.6	42.2	42.3	42.7

Shares outstanding: 39.61m at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.